Amilpar - Relevant Fact

Share

RIO DE JANEIRO, Dec. 21 Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR ; Reuters: AMIL3.SA), the largest managed care organization in Brazil, in accordance with article 157, paragraph 4, of Law 6,404/76 (Brazilian Corporate Law) and CVM Instruction nš 358/02, and in addition to the Relevant Facts released on November 19, 2009, December 2 and 9, 2009, informs its shareholders and the market that its subsidiary Amil Assistencia Medica Internacional Ltda. will proceed only with the mandatory public offer for the acquisition of shares issued by Medial Saude S.A. due to the change of control of this company (Tag Along) and will not, at the moment, promote public offer for the following purposes (a) exit of the Bovespa's Novo Mercado and (b) cancellation of the register of public company (delisting) of Medial Saude S.A.

Amilpar will keep the market and its shareholders informed about the conclusion of the above mentioned offer.

To access the Relevant Fact visit our website at www.amilpar.com.br/ir

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer